A Randomized, Open Label, Single-Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276 in Healthy Male Volunteers.

Trial Profile

A Randomized, Open Label, Single-Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276 in Healthy Male Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Aug 2016

At a glance

  • Drugs Olmesartan medoxomil; Olmesartan medoxomil/rosuvastatin; Rosuvastatin
  • Indications Hyperlipidaemia; Hypertension
  • Focus Pharmacokinetics
  • Most Recent Events

    • 03 Apr 2012 Actual end date (March 2012) added as reported by ClinicalTrials.gov.
    • 03 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Feb 2012 Additional trial identifier KCT0000325 and actual initiation date (18 Jan 2012) identified as reported by Clinical Research Information Service (CriS) - Republic of Korea record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top